These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 322579)

  • 21. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells.
    Gelfand MC; Paul WE
    J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intersex difference in the production of alloantibodies and growth of tumour allografts in mice.
    Kinsky RG; Hilgert I; Kristofová H
    Folia Biol (Praha); 1976; 22(4):253-63. PubMed ID: 964410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K.
    Cook RG; Jenkins RN; Flaherty L; Rich RR
    J Immunol; 1983 Mar; 130(3):1293-9. PubMed ID: 6822734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC antigens on mouse trophoblast cells: paucity of Ia antigens despite the presence of H-2K and D.
    Chatterjee-Hasrouni S; Lala PK
    J Immunol; 1981 Nov; 127(5):2070-3. PubMed ID: 6946147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: Specific inhibitor effect of sera of CBA mice immunized with CBA anti-A/Jax antibody on the formation of allogenic rosettes. Role of anti-idiotype antibody].
    Fuensalida E; Kinsky R; Duc HT
    Ann Immunol (Paris); 1975 Apr; 126(3):357. PubMed ID: 1180494
    [No Abstract]   [Full Text] [Related]  

  • 35. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.
    Voisin GA; Kinsky RG; Duc HT
    J Exp Med; 1972 May; 135(5):1185-203. PubMed ID: 4623319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic sites implicated in tumour allograft enhancement].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of in vitro and in vivo activities of isoantibodies directed against idiotypes and recognition structures for transplantation antigens.
    Kinsky RG; Duc HT; Fuensalida E
    Folia Biol (Praha); 1978; 24(2):81-94. PubMed ID: 26614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.